Rolf Kaiser

Board certified medical expert, clinical pharmacology (venia legendi), physician and chemist with more than 20 years of experience in leading international clinical drug development until successful registration. Current position at a first line regulatory authority “Swissmedic”. Former position as CMO of Boehringer-Ingelheim, Switzerland. Member of the Senior Management Program of Boehringer-Ingelheim. Research Awardee of Boehringer-Ingelheim in recognition of his important contributions in drug development for phase I-IV in various indications and disease stages. Various research prizes. Consultant for Deutsche Frauenhofer-Gesellschaft, ITEM, University of Regensburg.